Veterinary Artificial Insemination Market

Veterinary Artificial Insemination Market Analysis by Animal Type (Cattle, Swine, Ovine, Equine Veterinary Artificial Insemination), by Product (Normal Semen, Sexed Semen), by End User & Region - Global Forecast 2022-2032

Analysis of Veterinary Artificial Insemination market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Veterinary Artificial Insemination Market Outlook (2022-2032)

The veterinary artificial insemination market is forecast to garner a market value of US$ 3.16 Bn in 2022, anticipated to register a positive CAGR of 5.2% in the forecast period 2022-2032 and reach a value of US$ 5.24 Bn.

Report Attributes


Veterinary Artificial Insemination Market Size (2022)

US$ 3.16 Bn

Sales Forecast for Veterinary Artificial Insemination (2032)

US$ 5.24 Bn

Global Market Growth Rate (2022 to 2032)

5.2% CAGR

Key Companies Profiled

  • Genus ABS
  • URUS Group LP
  • CRV
  • Semex
  • VikingGenetics FmbA
  • Select Sires Inc.
  • Swine Genetics International
  • Shipley Swine Genetics
  • Stallion AI Services Ltd.
  • STGenetics

Demand Analysis of Veterinary Artificial Insemination from 2015-2021 Vs Future Outlook 2022-2032

From 2015 to 2021, the global veterinary artificial insemination market registered significant gains, reaching a valuation of US$ 3 Bn. As per Fact.MR- a market research and competitive intelligence provider- the market experienced a CAGR of 4% during the aforementioned historical period.

Growing demand for improved animal efficiency and productivity, demand for animal protein, supportive initiatives by industry stakeholders, need for sustainable food production, and adoption of sexed semen in developing markets are some of the key drivers of this market.

The industry players are continuously trying to develop new products along with partnerships, collaboration, and acquisitions to sustain their market share. Considering these factors, the market is projected to witness high growth over the coming years, registering a CAGR of 5.2% to reach a value of US$ 5.24 Bn by 2032.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

What is driving the Market Demand for Veterinary Artificial Insemination?

Rising Need to Multiply Livestock for Enhanced Yield Boosting Prospects

The artificial insemination technique has been commercially available for over 60 years and has been utilized very effectively in the cattle and dairy industry. Various factors such as the risks involved with animal breeding and disease transmission are the major factors leading to market growth. 

Increasing productivity using AI technology is boosting the market for veterinary artificial insemination. Female offspring born through artificial insemination are found to produce more milk than normal offspring. The use of semen extenders containing antibiotics is also helpful in preventing the transmission of bacterial diseases. Furthermore, the entire procedure of AI is considered to be much more hygienic than natural mating

Moreover, as the production conditions and the farmers' needs evolve, many of the animal breeds are no longer suitable for the majority of farms. However, artificial insemination is used as a preferred reproduction method for such breeds and makes it possible to continue to farm the breeds in situ. 

Demand for Ushering in Cattle Efficiency to Widen Artificial Insemination Adoption

Associated advantages such as increased efficiency of bull usage, genetic selection, decreased cost of housing, handling bull, and safety for farmers and animals are further anticipated to increase adoption of artificial insemination in the coming years. Increasing calf prices is also a major factor for adopting the AI technique. 

According to a report published by the Beef Cattle Research Council in March 2018, bull prices were USD 5,500 to USD 8,000 in Canada from 2015 to 2016. These prices decreased from USD 4,500 to USD 6,500 from 2017 to 2018 owing to the adoption of AI.

The demand for the genetically superior breed of animals is increasing, which in turn is increasing the demand for artificial insemination procedures in animals.  The industry players are continuously trying to develop new products along with partnerships, collaboration, and acquisitions to sustain their market share. For instance, in August 2020, Cogent collaborated with AB Europe, a sheep breeding company, to launch a novel sexed semen service for sheep producers in the U.K.

Country-wise Analysis

How is the U.S Propelling Market Demand for Veterinary Artificial Insemination?

Presence of a Robust Animal Husbandry Industry to Bolster Growth Prospects

According to Fact.MR, the US dominates the veterinary artificial insemination market, accounting for the largest revenue share of 30% in 2022. This is owing to the well-equipped animal husbandry industry, growing awareness and adoption of AI for breeding livestock, and the presence of key companies such as STgenetics.

STgenetics for instance is a leading player in the sexed semen market. The Sex Sorted Semen produced by the company offers an average of 93.0% female purity for various breeds of cattle and buffaloes.

What Drives the Demand for Veterinary Artificial Insemination in Asia Pacific Countries?

Presence of a Flourishing Dairy Industry encouraging Veterinary Artificial Insemination Adoption

In the Asia Pacific, the market for veterinary artificial insemination is estimated to witness the fastest CAGR of over 7% during the forecast period. Large cattle inventory, a thriving dairy industry, supportive government initiatives, and growing awareness about the benefits of artificially inseminating livestock are propelling the market growth. 

For instance, in 2020, the government allowed Milk Producer Companies to establish multipurpose AI technicians in rural areas following necessary approval to boost AI coverage in the country. Many milk-producing companies in India have also initiated doorstep AI delivery to support market growth.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Category-wise Insights

Which Product Type Leads the Market?

Growth Prospects Appear Bright for Normal Semen

The normal semen segment dominates the market for veterinary artificial insemination and accounts for the revenue share of 80%. The market is expected to maintain its position during the forecast period. The high segmental revenue is attributed to the low price of normal semen as compared to sexed semen and high fertility rates. 

The sexed semen segment is expected to show the fastest growth in the market for veterinary artificial insemination over the forecast period. This is due to increasing adoption to promote the rate of herd expansion and supportive government policies. 

In June 2021, the Indian government subsidized the price of sexed semen straws. This partnership between the government and Genus ABS would help dairy farmers in the Indian state of Maharashtra by bringing down the price of sex-sorted semen from USD 17.50 to USD 1. The Agriculture and Horticulture Development Board in the U.K. too reported a surge in sexed semen sales in 2020 owing to improvements in success rates and competitive pricing.

Which Animal Type is projected to Get Traction in the Market?

Cattle Segment highest Revenue Grosser, Swine Segment to be Fastest Growing

Based on animal type, the cattle segment accounts for the largest revenue share of over 36%. The swine segment on the other hand is projected to grow at the fastest rate of over 6% across the forecast period. 

This is owing to increasing advancements in bovine and swine genetics, widespread adoption of AI in cattle and pig breeding across key markets, and the need to produce sustainable animals. DanBred, based in Denmark for example, helps offer superior bovine genetics through DanBred AI. The semen and the genetic progress of the herd can be tracked with GenePro for better accountability and ROI.

Advancements in bovine genetics can be evaluated with the genetic base change numbers that quantify the actual progress made for each trait within a breed. The base change represents the adjusted Predicted Transmitting Abilities (PTAs) for each trait and for every animal in a breed. The number is reset to 0 every 5 years. Alta Genetics Inc. 

For instance, reported notable progress for the production traits in both Jerseys and Holsteins from 2015 to 2020. The company’s Holstein and Jersey breeds were rated favorably for production traits such as milk, fat, protein, Daughter Pregnancy Rate (DPR), and more.

Who Are The Top End-Users of the Market?

The animal husbandry segment dominated the market for veterinary artificial insemination and accounted for the largest revenue share of around 78.1% in 2021. The growth can be attributed to the majority of the semen collection and AI procedures being performed on-site in breeding farms. 

Moreover, increasing government initiatives, technological advancements, and demand for milk and protein are further increasing the adoption of AI technology. For instance, in June 2020 Indian government approved around USD 2.06 billion for Animal Husbandry Infrastructure Development Fund (AHIDF). 

The other segment comprising of veterinary hospitals and clinics is anticipated to grow at the fastest rate in the market for veterinary artificial insemination in the coming years. An increasing number of hospitals carrying out artificial insemination procedures in developed and developing countries, supportive initiatives, and the rising number of veterinarians are factors driving the market. 

For instance, as per the AI Development Plan launched in 2017 in China, the Chinese government describes artificial insemination as a new focal point of international competition and declared itself open to the world’s premier AI innovation center by 2030.

Competitive Landscape

The competitive landscape of the veterinary artificial insemination market is shaped by product innovation and strategic mergers & acquisitions. Front Runners are emphasizing capacity enhancements and global footprint expansion to leverage lucrative prospects in developing economies. 

  • In January 2022, Semex and Nedap announced the expansion of their successful partnership. The Semex ai24® program with Nedap technology is now available in more countries, enabling dairy farmers to significantly improve their herd performance and profitability.
  • In September 2021, LIC- an agritech co-operative based in New Zealand launched a sexed semen lab in the country to meet the growing demand. This boosted the co-operative’s capabilities to artificially inseminate about 4.5 million cattle between Spring mating season of September to December 2021.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Veterinary Artificial Insemination Market Report Scope

Report Attributes


Forecast Period


Historical Data Available for


Market Analysis

US$ Mn for Value 

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • MEA

Key Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Nordics
  • China
  • Japan
  • South Korea
  • Brazil
  • Mexico
  • GCC
  • Turkey
  • South Africa

Key Market Segments Covered

  • Product
  • Animal Type
  • End User
  • Region

Key Market Segments in Veterinary Artificial Insemination Industry Research

  • By Animal Type

    • Cattle Veterinary Artificial Insemination
    • Swine Veterinary Artificial Insemination
    • Ovine & Caprine Veterinary Artificial Insemination
    • Equine Veterinary Artificial Insemination
    • Other Animal Veterinary Artificial Insemination Types
  • By Product

    • Normal Semen
    • Sexed Semen
  • By End User

    • Veterinary Artificial Insemination for Animal Husbandry
    • Veterinary Artificial Insemination for Other End Users

- FAQs -

As of 2021, the veterinary artificial insemination market was valued at US$ 3 Bn

As of 2022, demand for veterinary artificial insemination is forecast to reach US$ 3.16 Bn

From 2015-2021, veterinary artificial insemination demand grew at a CAGR of 4%

From 2022-2032, demand for veterinary artificial insemination is expected to surge at a CAGR of 5.2%

According to Fact.MR, the veterinary artificial insemination industry is expected to be valued at US$ 5.24 Bn by 2032

Across the U.S, demand for veterinary artificial insemination is expected to accumulate 30% revenue by 2022

The Asia Pacific market for veterinary artificial insemination is poised to exhibit a CAGR of 7% from 2022 to 2032

Natural semen is expected to be the dominant product, capturing over 80% revenue

Cattle veterinary artificial insemination is forecast to remain popular, comprising 36% of total revenue

Veterinary Artificial Insemination Market

Schedule a Call

We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.

By clicking "Accept All", you consent to our use of cookies. Privacy Policy